'Know Your Potential' with Knosis – Cognizin® Citicoline Featured in New Nootropic + Energy Blend
KIRIN HLDGS CO LTD S/ADR (KNBWY)
US:NASDAQ Investor Relations:
kirinholdings.co.jp/english/ir
Company Research
Source: PR Web
NEW YORK (PRWEB) September 17, 2020 Dietary supplement brand Knosis enters the market with the launch of its powdered Energy + Nootropic mix, a science-backed formula designed by Knosis' founder Erik Bywater to optimally support eSports performance and energy. "Gamers aren't chained to our screens; we are also competitors, athletes, creators, entrepreneurs and hard workers who strive to be the best at whatever we do," he explains, "I wanted to create a novel nootropic for these niches that functions like a 'pre-workout' for your brain, and that was proven effective, without the questionable ingredients. That's why Kyowa Hakko's Cognizin® Citicoline ingredient is so critical to the efficacy and uniqueness of our product."Cognizin® Citicoline is a patented, branded form of citicoline that is made by leading international health ingredient manufacturer, Kyowa Hakko, through a fermentation process. Citicoline is a potent brain-health nutrient and nootropic that is especially vital to bra
Show less
Read more
Impact Snapshot
Event Time:
KNBWY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNBWY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNBWY alerts
High impacting KIRIN HLDGS CO LTD S/ADR news events
Weekly update
A roundup of the hottest topics
KNBWY
News
- First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome [Yahoo! Finance]Yahoo! Finance
- First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary SyndromeBusiness Wire
- First Interim Analysis of PROSPER Study Details Patient-Reported Symptom Burden of Mycosis Fungoides and Sézary Syndrome [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On Therapies [Yahoo! Finance]Yahoo! Finance
- Kyowa Kirin to Present a Safety Meta-Analysis of NOURIANZ® (istradefylline) and Other Parkinson's Disease Add-On TherapiesPR Newswire